Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ALX Oncology Holdings Inc.
IPO Date: July 17, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $30.23M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.90 | 3.94%
Avg Daily Range (30 D): $0.03 | 4.11%
Avg Daily Range (90 D): $0.06 | 5.04%
Institutional Daily Volume
Avg Daily Volume: .42M
Avg Daily Volume (30 D): .43M
Avg Daily Volume (90 D): .86M
Trade Size
Avg Trade Size (Sh.): 98
Avg Trade Size (Sh.) (30 D): 236
Avg Trade Size (Sh.) (90 D): 221
Institutional Trades
Total Inst.Trades: 825
Avg Inst. Trade: $1.85M
Avg Inst. Trade (30 D): $1.71M
Avg Inst. Trade (90 D): $1.08M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.96M
Avg Closing Trade (30 D): $.83M
Avg Closing Trade (90 D): $.83M
Avg Closing Volume: 74.95K
       
News
Mar 8, 2025 @ 12:33 PM
Why the Global Cancer Market Could Surpass $900 Bi...
Source: Prnewswire
Dec 18, 2024 @ 1:00 PM
ALX Oncology to Present Updated Results from Phase...
Source: Alx Oncology
Nov 1, 2024 @ 9:30 PM
ALX Oncology Announces Results from Phase 1b/2 Tri...
Source: Alx Oncology
Oct 1, 2024 @ 5:00 PM
Breast Cancer Clinical Trial Pipeline Appears Robu...
Source: Delveinsight
Jul 24, 2024 @ 8:02 AM
EnerVenue Names Steffen Pietzke as Chief Financial...
Source: N/A
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-2.58 $-.53 $-2.58
Diluted EPS $-2.58 $-.53 $-2.58
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -134.85M $ -29.16M $ -134.85M
Operating Income / Loss $ -142.47M $ -30.61M $ -142.47M
Cost of Revenue $ $ $
Net Cash Flow $ -4.84M $ 1.47M $ -4.84M
PE Ratio